Related Experiment Video
Updated: May 4, 2026
10:05
Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
7.7K
Antineoplastic DNA-binding compounds: intercalating and minor groove binding drugs
Arhiv Za Higijenu Rada I Toksikologiju
|January 4, 2014
Summary
DNA intercalating and minor groove binding compounds are novel antineoplastic agents derived from natural sources. These compounds target DNA to induce cancer cell death, offering new chemotherapy strategies.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Pharmacology
Background:
- Malignant diseases require novel therapeutic strategies.
- DNA-targeting compounds offer a promising approach for cancer treatment.
- Naturally derived compounds are a rich source for developing antineoplastic agents.
Purpose of the Study:
- To provide an overview of DNA intercalating and minor groove binding compounds.
- To explain the chemical structures, origins, and mechanisms of action.
- To discuss their application in chemotherapy.
Main Methods:
- Literature review of DNA intercalating and minor groove binding compounds.
- Analysis of chemical structures and natural origins.
- Explanation of mechanisms involving DNA interaction and topoisomerase inhibition.
Main Results:
- Identified DNA intercalators and minor groove binders as key antineoplastic agents.
- Elucidated mechanisms of action, including topoisomerase poisoning.
- Highlighted their derivation from natural sources like microorganisms and plants.
Conclusions:
- DNA intercalating and minor groove binding compounds represent a significant advancement in cancer chemotherapy.
- Their ability to interfere with DNA replication and cell cycle progression is crucial for their efficacy.
- Further development of these natural product derivatives holds potential for improved cancer treatment outcomes.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
130
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
130
01:10Drugs that Destabilize Microtubules
3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
01:25Drug-Receptor Bonds
4.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.8K
01:26Targets for Drug Action: Overview
9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
01:15Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
01:03Single-Strand DNA Binding Proteins
12.9K
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
12.9K